Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Miragen Therapeutics Inc (MGEN)

1.12   -0.01 (-0.88%) 08-13 16:00
Open: 1.13 Pre. Close: 1.13
High: 1.13 Low: 1.1
Volume: 770,058 Market Cap: 63M
Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.132 - 1.139 1.139 - 1.144
Low: 1.084 - 1.093 1.093 - 1.099
Close: 1.108 - 1.121 1.121 - 1.131

Technical analysis

as of: 2020-08-13 4:36:17 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.51     One year: 1.88
Support: Support1: 0.79    Support2: 0.66
Resistance: Resistance1: 1.30    Resistance2: 1.61
Pivot: 1.14
Moving Average: MA(5): 1.13     MA(20): 1.12
MA(100): 0.84     MA(250): 0.82
MACD: MACD(12,26): 0.03     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 21.52     %D(3): 22.69
RSI: RSI(14): 52.20
52-week: High: 2.27  Low: 0.31  Change(%): 23.1
Average Vol(K): 3-Month: 327592  10-Days: 138157

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MGEN has closed above bottom band by 40.3%. Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MGEN's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 11 Aug 2020
Miragen Therapeutics (MGEN) Quarterly Performance is 75.76%: Here is the Surprise Factor - The InvestChronicle

Thu, 06 Aug 2020
Boulder-based MiRagen says it has cash to last through late 2021 - The Daily Camera

Wed, 05 Aug 2020
miRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates - GlobeNewswire

Tue, 28 Jul 2020
miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data in Nucleic Acid Therapeutics - GlobeNewswire

Mon, 27 Jul 2020
Roll up the Sleeves! When the bell rang at previous close Miragen Therapeutics (MGEN) was up 2.42% - The InvestChronicle

Fri, 24 Jul 2020
Miragen Therapeutics Inc (MGEN) Receives Orphan Drug Designation by FDA; Stock Up 23.64% - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 53
Shares Float (M) 47
% Held by Insiders 5.66
% Held by Institutions 16.94
Shares Short (K) 1,170
Shares Short P. Month (K) 322

Stock Financials

EPS -1.094
EPS Est This Year -1.520
EPS Est Next Year -1.660
Book Value (p.s.) 0.510
Profit Margin
Operating Margin -734.64
Return on Assets (ttm) -48.0
Return on Equity (ttm) -112.7
Qtrly Rev. Growth 122.6
Gross Profit (p.s.) -0.539
Sales Per Share 0.093
EBITDA (p.s.) -0.675
Qtrly Earnings Growth
Operating Cash Flow (M) -33
Levered Free Cash Flow (M) -17

Stock Valuations

PE Ratio -1.02
PEG Ratio
Price to Book value 2.20
Price to Sales 12.08
Price to Cash Flow -1.82

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.